Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Assets (2014 - 2026)

Updated

Zevra Therapeutics (ZVRA) posted Assets of $302.71 million for Q2 2026, up 18.1% from $256.28 million a year earlier and up 8.7% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Zevra Therapeutics' Assets came in at $284.73 million, up 59.8% from FY2024.

  • Annual Assets has increased for three consecutive years, with a five-year compound annual growth rate of 91.0% (FY2020 to FY2025).
  • In prior years, Zevra Therapeutics' Assets was $178.13 million in FY2024 (+3.4%), $172.33 million in FY2023 (+49.4%), $115.34 million in FY2022 (-13.2%) and $132.94 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2014.
  • On a year-over-year basis, Assets has increased in each of the last 12 quarters, with growth averaging 39.1% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was Q2 2025, with growth of 77.5%; the weakest was Q1 2023, with a decline of 15.2%.
  • According to Business Quant data, Assets for the three prior quarters was $278.58 million (Q1 2026), $284.73 million (Q4 2025) and $270.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 201.06 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 135.12 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 115.83 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 27.42 Bn
10 Zevra Therapeutics 672.94 Mn -139.77 Mn 38.18 Mn 302.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 302.71 Mn
Mar 31, 2026 278.58 Mn
Dec 31, 2025 284.73 Mn
Sep 30, 2025 270.12 Mn
Jun 30, 2025 256.28 Mn
Mar 31, 2025 172.71 Mn
Dec 31, 2024 178.13 Mn
Sep 30, 2024 191.55 Mn
Jun 30, 2024 144.41 Mn
Mar 31, 2024 151.28 Mn
Dec 31, 2023 172.33 Mn
Sep 30, 2023 138.98 Mn
Jun 30, 2023 105.52 Mn
Mar 31, 2023 106.60 Mn
Dec 31, 2022 115.34 Mn
Sep 30, 2022 119.55 Mn
Jun 30, 2022 124.26 Mn
Mar 31, 2022 125.71 Mn
Dec 31, 2021 132.94 Mn
Sep 30, 2021 137.19 Mn
API Access

Zevra Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY